The only company which is a clear growth vehicle in our view is Schering-Plough.

The only way this company can improve their earnings is through pursuing a merger or by being acquired. It's not very innovative, but it's what they're going to have to do.

Pfizer clearly is a company with tremendous disregard for the generic drug industry and is not given to settling. But it is not altogether unlikely that Pfizer could settle its litigation. If Pfizer could translate some of its cash hoards into greater certainty on this litigation ... I think they would do that.

He's not getting the kind of diversification he thinks because they're all in large company growth, ... If he held small company funds or value funds or foreign, he'd have wider diversification, and far lower risk.

This is not a company that's on the ropes, but I think it's struggling to maintain the growth targets it has set for itself.

Tropicana is a great grocery brand. Tropicana is already showing growth, so PepsiCo is buying a company with momentum.